Tavo Biotherapeutics
PrivateLast Round
Series A
Jun 2, 2026
Total Funding Raised
$17M
Momentum Score
25 /100
Company Overview
Tavo Biotherapeutics is a biopharmaceutical company developing novel therapeutics for ophthalmic diseases.
Sector
Healthcare & Life Sciences
Verticals
Biotechnology, Drug Discovery, Clinical Trials
Business Model
B2B2C
Customer Profile
Government Contracts
AI Layer
Non-AI
Keywords
Historical Pricing
Historical view of private secondary pricing and transaction trends.
Tavo Biotherapeutics Comps
Public and private peers based on sector, stage, and business model.
Tavo Biotherapeutics Funding Rounds
Historical fundraising activity
| Round | Date | Amount Raised | Valuation | Investors | Sources |
|---|---|---|---|---|---|
| Series A | Jun 2, 2026 |
Key People
Founding team and executive leadership
Tavo Biotherapeutics Investors
Notable investors and investment history
| Investor | Rounds |
|---|---|
| Tau Capital | Series A |
| Pureos Bioventures | Series A |
| Polaris Partners | Series A |
Market signals
Structured signals derived from secondary market and firmographic data.
- Jun 2, 2026
$17M round led by Pureos Bioventures.
- Apr 2, 2026
Monthly visitors increased 74% MoM, reaching 3K.
Tavo Biotherapeutics Filings
SEC and related filings with document metadata.
| Typed | Date | Amount Offered | Amount Sold | Filling | Pages | Download |
|---|---|---|---|---|---|---|
Mock Valuation | Sign Up to view | Mock Valuation | Sign Up to view | Mock Valuation | Sign Up to view | Mock Valuation |
Mock Valuation | Sign Up to view | Mock Valuation | Sign Up to view | Mock Valuation | Sign Up to view | Mock Valuation |
Mock Valuation | Sign Up to view | Mock Valuation | Sign Up to view | Mock Valuation | Sign Up to view | Mock Valuation |
Mock Valuation | Sign Up to view | Mock Valuation | Sign Up to view | Mock Valuation | Sign Up to view | Mock Valuation |
Frequently Asked Questions
Common questions about Tavo Biotherapeutics's valuation, stock price, and market status.
